cardiovascular risk profile in our patients. Different from cutaneous cholesterol deposits that disappeared within months functional cardiovascular changes seem to take longer to regress. It may be important to start effective treatment as early in live as possible and to take other risk factors for atherosclerotic changes into account. 
INTRODUCTION AND AIMS:
Metalloprotease ADAMTS13 is a natural regulator of thrombus formation. Moderate deficiency of ADAMTS13 may occur with different microangiopathic syndromes, which can contribute to the process of thrombus formation.We conduct a comparative evaluation of ADAMTS13 activity in patients with STEC-HUS and aHUS. METHODS: 118 patients with STEC-HUS diagnosis (mean age 2.88 6 2.29 years) and 54 with aHUS after acute intestinal infection (AII) were examined (mean age 5.1 6 3.67 of the year). The activity of ADAMTS13 was determined by the method of FRET (fluorescence resonance energy transfer) using the fluorogenic substrate FRETS-VWF73 (PeptaNova GmbH, Germany). The activity of ADAMTS13 in healthy individuals is 80-122%. RESULTS: ADAMTS13 activity in children with STEC-HUS was 63.5 6 20.46% (19-132%) , with a deficit revealed in 78.8% of cases. In patients with aHUS, the activity of metalloprotease corresponded to 72.8 6 23.8% (30-131%), with a deficit was detected in 66.7% of children. The course of AII in 65.2% of patients with STEC-HUS showed hemocolitis. In the group of patients with aHUS hemoccolitis was noted in 9 (16.7%) children, in 6 (11.1%) cases, EHEC was detected by PCR, and in other cases, virus-associated diarrhea was diagnosed (Coxsackie virus type V, noravirus, rotavirus, adenovirus). Severity of anemia (65,9 6 12,7 vs 64,7 6 11,6 g / l), thrombocytopenia (61,1 6 31,6 vs 50,43 6 29,9[109 / l) and azotemia (461,8 6 206 vs 312.3 6 216.1 lmol / L) did not differ among patients with STEC-HUS and aHUS. The LDH and D-dimer values were 1.5 times higher in patients with STEC-HUS (3613 6 2615 vs 2921 6 1851.2 U / l; 3912.7 6 2524 vs 2692 6 1268 U / L, respectively), but the duration of thrombocytopenia was higher in patients with aHUS (11.6 6 5.6 vs 25 6 19.5 days). With STEC-HUS, the development of anuria (83.9% vs 35.7%), cortical necrosis (15.2% vs 5.5%), and the need for RRT was higher (87.3% vs 53.7% ). Among patients with aHUS, in comparison with patients with STEC-HUS, multiorgan failure were more frequent (83.9% vs 47.4%) due to the development of extrarenal manifestations from the central nervous system (71.4% v 42.4%), cardiovascular system 81.5% vs 35.6%), development of pancreatitis (11.1% vs 6.8%). Mortality was also higher in the group of children with aHUS (11.1% vs 2.5%). The lowest activity of ADAMTS13 was associated with the most severe course of both STEC-HUS and aHUS. CONCLUSIONS: Decrease in ADAMTS13 activity makes an additional contribution to the development of pathological thrombus formation in both endothelial dysfunction and complement hyperactivation. The low activity of the metalloprotease indicates a high probability of severe TMA. 
Children with idiopathic nephrotic syndrome (NS) treated with high doses of glucocorticoids (GCs) have increased apetite and are overweight. Changes in serum levels of leptin, ghrelin and obestatin -peptides regulating apetite, may influence severity of obesity. The aim of the study was to evaluate the serum concentrations of leptin, ghrelin and obestatin in children with nephrotic syndrome. METHODS: 25 children with 1 st episode of nephrotic syndrome aged 6 62,5 years (group I) and 20 healthy children aged 6,3 6 2,1 years (group II) were enrolled into the study. In all children anthropometric measurements (SDS BMI, waist hip ratioWHtR) and serum levels of leptin, ghrelin and obestatin were evaluated in group 1 before the treatment (0), in remission (R) and after 1 and 6 months of treatment in group I and once in the group II.
RESULTS: Children with NS had significantly higher (p<0,05) SDS BMI and WHtR in 0, R and 1 month of treatment in comparison to the group II. Mean leptin level was significantly lower during NS episode (0) compared to levels in remission, 1 and 6 month of treatment, but they did not differ from group II (6 66, 18, 11, 85615, 3, 9, 9469, 71, 22, 56 39, 5, 22 ,5 6 39 vs 21,8 þ/-44,3 ng/ml respectively, NS). In group I mean obestatin levels in 0, R, 1,6 were significantly lower in comparison to the group II (64,5 683,2, 118,6 6 154, 81,8 6 139,9, 11,2 6 14,3 vs 251,9 6 416,1 p<0,01 respectively). No correlations were found between levels of measured hormones and prednisone dose and SDS BMI or WHtR. CONCLUSIONS: Low obestatin levels in children with NS during steroid therapy may influence on appetite and increase in weight. Values of the IgA/C3 ratio are associoated with a corresponding confidence interval for specific MEST scores. The aim of the study was to asses of the significance of serum GDIgA1 level and GDIgA1/C3 serum ratio in predicting the prognosis of the disease. METHODS: Study population consisted of 42 children (15 IgAN and 27 HSN) and 22 in control group. Evaluations at baseline and at the end of follow-up included determination of proteinuria, haematuria, creatinine and IgA, C3 levels, glomerular filtration rate (GFR) and recording the presence of hypertension (HT). Kidney biopsy findings were evaluated using the Oxford classification (1-changes present, 0-absent: M-mesangial hypercellularity; E-endocapilary hypercellularity; S-segmental sclerosis/adhesion; T-tubular atrophy/interstitial fibrosis T0 0-25%, T1 26-50%, T2>50%) and MEST score was calculate as a sum M, E, S, T. At the follow up the serum level of GDIgA1 and GDIgA1/C3 serum ratio was measured. RESULTS: Serum level of GDIgA1 was significantly higher in IgAN and HSN patients than in control group (IgAN 4549.32 6 2302.95, HSN 4329.58 6 5072.58 vs control group 1688.72 6 1698.20 ng/ml, p<0.001).No differences were found in proteinuria, hematuria, GFR, MEST score, serum GDIgA1, GDIgA1/C3 serum ratio and period of observation between IgAN and HSN children. The age of the onset, IgA and time of the biopsy was higher in IgAN than HSN.We found positive correlation between GDIgA1 and IgA (r¼0,49), creatinine (r¼0,37), but not GFR at the follow up and not DGFR. We not observed any correlation between GDIgA1 and proteinuria, hematuria, hypertension, MESTscore. CONCLUSIONS: The prognostic significance of GDIgA1 or GDIgA1 / C3 in the examined group of children with IgAN and HSN has not been confirmed, but the study does not include the dynamics of parameters and requires further research. laboratory and histological data were collected from the medical files. The primary endpoint was proteinuria remission defined as a proteinuria 200 mg/24h. RESULTS: The mean age of these 18 patients (9 girls, 9 boys) at the time of diagnosis was 9.5 years (range 3.2-17.3 years). Nine patients (50%) responded to Pozzi protocol treatment and maintain complete remission over time. The other 50% remained with persistent proteinuria and all were treated by Cyclophosphamide, in this group, 5 patients (55.6%) maintained complete remission and 4 patients (44.4%) patients remained with persistent proteinuria. Univariate analysis found a higher likelihood of response to Pozzi protocol in: older children 11.864.1 years (p ¼ 0.016), in patients with longer period passed between skin manifestation (purpura) and nephrotic range proteinuria (median 30 [14.5-45] days), (p ¼ 0.05), in patients with lower 24-hour urine protein to creatinine ratio (p ¼ 0.026) and higher glomerular filtration rate (GFR) at presentation (p ¼ 0.034). CONCLUSIONS: Our study shows 50% response to treatment by Pozzi protocol in HSPN patients who presented with nephrotic range proteinuria. Time between skin and renal manifestations, age, GFR and 24-hour urine to creatinine ratio at presentation have been found to be predictive for treatment outcomes. CONCLUSIONS: This study showed that girls as well as boys with XLAS had high prevalence of hematuria and decreased eGFR. Moderate proteinuria and hearing loss were prevalent in boys with XLAS. Our findings confirmed, that girls with XLAS may have similar to boys' phenotype that need early diagnostics and treatment to prevent progression to ESKD.
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FP781 RENALASE IN CHILDREN WITH CHRONIC KIDNEY DISEASE
Piotr Skrzypczyk 2 , Magdalena Okarska-Napierała
INTRODUCTION AND AIMS:
Renalase is a catecholamines inactivating enzyme produced mainly by renal proximal tubule cells. Animal studies and studies in adults with kidney disease suggest that renalase may play role in pathogenesis of hypertension and target organ damage. The aim of the study was to assess level of renalase in children with chronic kidney disease and to find the relation between renalase level and clinical parameters in this group of patients. METHODS: In 38 children (21 boys, 17 girls) aged from 4.91 to 18.0 mean: 12.2364.19 years with chronic kidney disease we evaluated serum renalase level (Cloud Corp. WUHAN, China) [lg/mL], BMI Z-score, arterial stiffness parameters (pulse wave analysis, pulse wave velocity -PWV, Sphygmocor, AtCor Medical, Australia), peripheral and central blood pressure (Welch Allyn VSM 300 Patient Monitor, Welch Allyn, USA and Sphygmocor, respectively), intima-media thickness (IMT) (ALOKA Prosound Alpha 6, ALOKA-Hitachi, Japan), medications used, kidney function (GFR ac. to Schwartz formula), and selected biochemical parameters. Control group included 38 healthy children (19 boys, 19 girls), aged from 5.51 to 18.00 mean 11.7963.29 years.
RESULTS: In the study group GFR was from 4.19 to 85.55 mean 25.7468.94 mL/min/ 1.73 m 2 , 14 children were in stage G2 CKD, 11 in stage G3, 6 in stage G4 and 7 in stage G5 (6 children were dialysed: 5 were on peritoneal dialysis, 1 on hemodialysis); 26 children had arterial hypertension. Mean renalase level in the study group was from 0.93 to 114.16 mean 59.45623.25 [lg/mL] and was significantly higher compared to control group (27.2065.15 [ug/mL] ) (p¼0.0001). In children with CKD renalase level correlated with BMI Z-score (r¼-0.36, p¼0.027) and mean alphacalcidol dose [lg/24h] (r¼0.41, p¼0.02) . In addition, in the study group we found significant correlations of renalase with p¼0.00001), p¼0.002), phosphate (r¼0.35, p¼0.03), p¼0.03), parathormone (r¼0.58, p¼0.0001), total cholesterol (r¼0.35, p¼0.03) , p¼0 .03) and triglycerides (r¼0.52, p¼0.01). We found no correlations between renalase level and peripheral and central blood pressure and IMT ([cm] and Z-score); renalase level was significantly correlated with pulse wave velocity Z-score (r¼0.42, p¼0.043). In the control group renalase was correlated only with age (r¼-0.37, p¼0.022); such relation was not found in the study group. No other significant correlations between renalase and analyzed clinical, vascular and biochemical parameters were found in the control group. CONCLUSIONS: 1. In children with chronic kidney disease renalase level is higher compared to healthy peers and is highly dependent on glomerular filtration. 2. In children with chronic kidney disease renalase seems to be related neither to central nor to peripheral blood pressure but may be a marker of arterial stiffness. 
Nephrtoic syndrome is known complication of cyanotic heart disease. the pathophysiology is theorized to be secondary to polycythemia and chronic hypoxia. There is no agreement on best treatment in previous literature.
Here we report a case of child of complex cyanotic heart disease who developed nephrotic syndrome that was successfully treated by directly targeting the mechanism of disease. METHODS: A 12 year old boy born with complex cyanotic heart disease underwent multiple corrective procedure. Despite that, he continued to have cyanotic disease, chronic hypoxia with O2 sat regularly in 60-80%. As a result he had polycythemia with hemoglobin 20-23 gm/dl. Patient was on regular monthly venesection secession in attempt to control polycythemia. His long term medication were warfarin, aspirin and enalapril. At the age of 11 years he presented with generalized edema. Lab test showed low serum albumin 18 g/l, elevated urinary protein to creatinine ratio 4.88 g/g. Kidney function was normal, creatinine 28 micromole/L. The need for kidney biopsy was discussed with the family, however, due to complexity of the case and the need for continues use of anticoagulants, kidney biopsy was not performed. A trial of prednisolone 1.5 mg/kg/dose for 6 weeks followed by tapering dose for another 8 weeks when it was completely discontinued . The patient had no response to steroids. He continued to have edema, low serum albumin and proteinuria. With persistent of nephrotic state a decision was made, after discussion with cardiologist and hematologist, to intensify the venesection frequency to biweekly to decrease patient hemoglobin and maintain it at a target of 16-17g/dl. RESULTS: After applying the intensified venesection regimen, a concurrent decline in hemoglobin and proteinuria occurred as appears in the figure.
Patient edema completely resolved and serum albumin improved gradually. CONCLUSIONS: Remission of nephrotic syndrome in a child with cyanotic heart disease and secondary polycythemia was achieved with frequent venesection to decrease hemoglobin level toward normal. This strategy of treatment, in this case, succeeded while ACE inhibitors and steroids did not have any therapeutic effect.Avoidance of prolonged polycythemia in children with cyanotic heart disease may prevent the development of proteinuria and/or nephrotic syndrome.
